PND1 Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-Effectiveness

dc.contributor.author	Kostyuk, A.
dc.contributor.author	Nurgozhin, T.
dc.contributor.author	Akanov, A.
dc.creator	A., Kostyuk
dc.date.accessioned	2017-12-15T06:22:23Z
dc.date.available	2017-12-15T06:22:23Z
dc.date.issued	2014-11-01
dc.identifier	DOI:10.1016/j.jval.2014.08.538
dc.identifier.citation	A. Kostyuk, T. Nurgozhin, A. Akanov, PND1 - Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-Effectiveness, In Value in Health, Volume 17, Issue 7, 2014, Pages A808-A809	en_US
dc.identifier.issn	10983015
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S1098301514024681
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/2943
dc.language.iso	en	en_US
dc.publisher	Value in Health	en_US
dc.relation.ispartof	Value in Health
dc.title	PND1 Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-Effectiveness	en_US
dc.type	Article	en_US
dc.rights.license	Copyright © 2014 Published by Elsevier Inc.
elsevier.identifier.doi	10.1016/j.jval.2014.08.538
elsevier.identifier.eid	1-s2.0-S1098301514024681
elsevier.identifier.pii	S1098-3015(14)02468-1
elsevier.volume	17
elsevier.issue.identifier	7
elsevier.coverdate	2014-11-01
elsevier.coverdisplaydate	November 2014
elsevier.startingpage	A808
elsevier.endingpage	A809
elsevier.openaccess	1
elsevier.openaccessarticle	true
elsevier.openarchivearticle	true
elsevier.openaccessuserlicense	http://www.elsevier.com/open-access/userlicense/1.0/
elsevier.aggregationtype	Journal
workflow.import.source	science